Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts.
What is the forecasted revenue size of the life science reagents industry by 2029?
The life science reagents market size has grown strongly in recent years. It will grow from $52.31 $ billion in 2024 to $56.16 $ billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to advancements in molecular biology, increased funding for research, the rising prevalence of chronic diseases, the rise of personalized medicine, and global health crises.
The life science reagents market size is expected to see strong growth in the next few years. It will grow to $73.84 $ billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to the aging population and chronic diseases, advancements in diagnostic technologies, increase in research and development spending, adoption of high-throughput screening, and regulatory and quality standards. Major trends in the forecast period include increased demand for high-purity reagents, the rise of automation and high-throughput technologies, sustainability and green chemistry, integration of artificial intelligence and machine learning, and growth in life science research.
Download Your Free Sample PDF:
Which industry-specific innovations are acting as key drivers for the life science reagents market?
The rising prevalence of infectious diseases is expected to propel the growth of the life science reagents market going forward. Infectious diseases are illnesses caused by pathogens such as bacteria, viruses, fungi, or parasites that can spread from one person to another or through environmental sources. The rising prevalence of infectious diseases is often due to factors such as increased global travel, urbanization, climate change, and antibiotic resistance. Life science reagents are used in infectious diseases for diagnostics, research, and the development of treatments by enabling the detection and analysis of pathogens. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2022, the number of reported tuberculosis (TB) cases in the United States increased to 8,331, compared to 7,870 cases reported in 2021. This represents a rise of 461 cases, or approximately 5.9%, indicating a slight upward trend in TB cases over the year. Therefore, the rising prevalence of infectious diseases is driving the growth of the life science reagents market.
Which segment currently leads the life science reagents market in terms of revenue share?
The life science reagentsmarket covered in this report is segmented –
1) By Product: Chromatography Reagents, Molecular Diagnostic Reagents, Clinical Chemistry Reagents, Flow Cytometry Reagents, Cell And Tissue Culture Reagents, Hematology And Hemostasis Reagents, Microbiology Reagents, Other Products
2) By Application: Protein Synthesis And Purification, Gene Expression, Deoxyribonucleic Acid (DNA) And Ribonucleic Acid (RNA) Analysis, Drug Testing, Other Applications
3) By End Use: Hospitals And Diagnostics Laboratories, Commercial And Contract Research Manufacturers, Academic And Research Institutes, Manufacturers, Other End Uses
Subsegments:
1) By Chromatography Reagents: Mobile Phases, Stationary Phases, Buffer Solutions, Detection Reagents, Column Reagents
2) By Molecular Diagnostic Reagents: PCR Reagents, Enzymes And Primers, Hybridization Probes, Reagents For Next-Generation Sequencing (NGS), CRISPR/Cas9 Reagents
3) By Clinical Chemistry Reagents: Blood Glucose Reagents, Electrolyte Testing Reagents, Liver Function Reagents, Kidney Function Reagents, Enzyme And Hormone Reagents
4) By Flow Cytometry Reagents: Fluorescent Antibodies, Flow Cytometry Buffers, Cytokine Detection Reagents, DNA Stains, Viability Stains
5) By Cell And Tissue Culture Reagents: Growth Media, Serum Supplements, Cell Culture Reagents, Growth Factors, Trypsin and Enzymes
6) By Hematology and Hemostasis Reagents: Blood Coagulation Reagents, Hemoglobin Test Reagents, Complete Blood Count (CBC) Reagents, Platelet Count Reagents, Clotting Factor Reagents
View The Full Market Report:
How are emerging trends transforming the life science reagents market dynamics?
Major companies operating in the life science reagents market are focused on developing innovative solutions, such as customizable light settings, to optimize experimental conditions, improve accuracy in research, and enhance the study of light-dependent organisms. Customizable light settings refer to the ability to adjust light intensity, color, and duration to meet specific experimental or environmental needs. For instance, in June 2023, Beckman Coulter Life Sciences, Inc., a US-based manufacturing company focused on life sciences and laboratory equipment, launched the microbioreactor light array module to facilitate the cultivation of photosynthetically active microalgae and microorganisms. The Light Array Module (LAM) for the BioLector XT Microbioreactor is specifically designed for light-dependent organisms, offering customizable light settings within the 400-700 nm spectrum. Controlled by 16 different LED types, it delivers high irradiance of up to 3500 µmol/m2/s. The BioLector XT also supports the growth of microbial, fungal, and algal species, featuring real-time monitoring of biomass, pH, dissolved oxygen, and fluorescence.
Who are the top competitors in the global life science reagents market?
Major companies operating in the life science reagents market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck Group, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Health Sciences Inc, Bio-Rad Laboratories Inc., Bio-Techne Corp, Promega Corporation, Genscript Biotech Corporation, Sino Biological Inc., New England Biolabs Inc., Kaneka Corporation, OriGene Technologies Inc., SeraCare Life Sciences Inc., Cayman Chemical Company, Takara Bio USA Inc., Cell Signaling Technology, Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Creative Diagnostics, HyTest Ltd, Geno Technology Inc., MyBiosource Inc., Fritz Hoffmann-La Roche, Enzo Life Sciences Inc.
What regional dynamics are shaping the future of the global life science reagents market?
North America was the largest region in the life science reagents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the life science reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Life Science Reagents Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
Need Customized Data On Life Science Reagents Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment